Fox Run Management, L.L.C. Crispr Therapeutics Ag Transaction History
Fox Run Management, L.L.C.
- $608 Million
- Q1 2025
A detailed history of Fox Run Management, L.L.C. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 18,473 shares of CRSP stock, worth $716,198. This represents 0.1% of its overall portfolio holdings.
Number of Shares
18,473Holding current value
$716,198% of portfolio
0.1%Shares
7 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
62.9MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$394 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$235 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$147 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$108 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$98.5 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.02B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....